Azonia derivatives of the γ-carboline system. A new class of DNA intercalators

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 13, 1996, Pages 1453-1456

  Molina, Andrés ^a   Vaquero, Juan J ^a   García Navio, José L ^a   Alvarez Builla, Julio ^a   Rodrigo, María M ^a   Castaño, Obis ^a   De Andres, José L ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA CARBOLINE DERIVATIVE; INTERCALATING AGENT;

ARTICLE; CHEMICAL REACTION; DRUG CYTOTOXICITY; DRUG DNA INTERACTION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

EID: 0030576288     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00243-0     Document Type: Article

References (23)

1. 1. Wilson, W. D.; Jones, R in Intercalation Chemistry, Whittingham, M. S.; Jacobson, A. J. Eds.; Academic Press, New York, 1981; Chapter 14.
2. 2. Gallego, J.; Ortiz, A. R.; Gago, F. J. Med. Chem. 1993, 36, 1548.
3. 3. (a) Gallego, J.; Luque, F. J.; Orozco, M.; Burgos, C.; Alvarez-Builla, J.; Rodrigo, M. M.; Gago, F. J. Med. Chem. 1994, 37, 1602.
4. (b) Gallego, J.; Luque, F. J.; Orozco, M.; Gago, F. J. Biomol. Str. & Dyn. 1994, 12, 111.
5. 4. Pastor, J.; Siró, J.; García-Navío, J. L.; Vaquero, J. J.; Rodrigo, M. M.; Ballesteros, M.; Alvarez-Builla, J. Bioorg. Med. Chem. Lett. 1995, 5, 3043.
6. 5. Graebe, C.; Ullman, F. Justus Liebigs Ann. Chem. 1896, 291, 16.
7. 6. For a preliminary communication: Molina, A.; Vaquero, J. J.; Garcia-Navio, J. L.; Alvarez-Builla, J. Tetrahedron Lett. 1993, 34, 2673.
8. 7. For recent examples see: (a) Santiesteban, I.; Siro, J. G.; Vaquero, J. J.; García-Navio, J. L.; Alvarez-Builla, J.; Castaño, O.; Andrés, J. L. J. Org. Chem. 1995, 60, 5667.
9. (b) Diaz, A.; Matia, M. P.; García-Navío, J. L.; Vaquero, J. J.; Alvarez-Builla, J. J. Org. Chem. 1994, 59, 8294.
10. 8. For criteria on the mode of binding to DNA see: (a) Suh, D.; Chaires, J. B. Bioor. Med Chem. 1995, 3, 723.
11. (b) Long, E. C.; Barton, J. K. Acc. Chem. Res. 1990, 23, 2773.
12. 9. Binding commonly results in hypochromism and a shift of the transition to longer wavelength in the intercalated chromophore. (a) Dougherty, G.; Pigram, W. J CRC Crit. Rev. Biochem. 1982, 12, 103.
13. (b) Berman, H. M.; Young, P. R. Annu. Rev. Biophys. Bioeng. 1981, 10, 87.
14. 10. McGhee, J.D.; von Hippel, P. H. J. Mol. Biol. 1974, 86, 469.
15. 11. Cohen, S. N.; Yielding, K. L. J. Biol. Chem. 1965, 240, 3123
16. 12. (a) Cory, M.; Tidwell, R. R.; Fairley, T. A. J. Med. Chem. 1992, 35, 431.
17. (b) Fairley, T. A.; Tidwell, R. R.; Donkor, I.; Naimen, N. A.; Ohemeng, K. A.; Lombardy, R. J.; Bentley, J. A.; Cory, M. J. Med. Chem. 1993, 36, 1746.
18. +, 100); 205 (26); 182 (14).
19. 14. Braña, M. F.; Castellano, J. M.; Morán, M.; Pérez de la Vega, M. J.; Romerdahl, C. A.; Quian, X-D.; Bousquet, P.; Emling, F.; Schlick, E.; Keilhauer, G. Anticancer Drug Res. 1993, 8, 257.
20. 15. (a) Insight-II, version 2.2.0, 1994; Biosym Technologies Inc., 9685 Scranton Road, San Diego, CA 92121-2777.
21. (b) Gaussian 92, Revision D.2, Frisch, M. J.; Trucks, G. W.; Head-Gordon, M.; Gill, P. M. W.; Wong, M. W.; Foresman, J. B.; Johnson, G.; Schlegel, H. B.; Robb, M. A.; Replogle, E. S.; Gomperts, R.; Andres, J. L.; Raghavachari, K.; Binkley, J. S.; González, C.; Martin, R. L.; Fox, D. J.; Defrees, D.J.; Baker, J.; Stewart, J. J. P.; Pople, J. A.; Gaussian, Inc., Pittsburgh PA, 1992.
22. 16. For a detailed discussion of binding parameters for ethidium bromide see: (a) Graves, D. E.; Watkins, C. L.; Yielding, L. W. Biochemistry, 1981, 20, 1887.
23. (b) Dougherty, G.; Pigram, J. W. CRC Crit. Rev. Biochem., vol, 12, p. 103-132, 1982.